Treatment with Interferon Gamma Enhances Fibrinolysis in Systemic Sclerosis - a disease related to damaged proteins

Author： Gluszko P.   Undas A.   Kwasny B.   Musial J.   Szczeklik A.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.91, Iss.4, 1998-08, pp. : 203-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Sclerosis-Related Interstitial Lung Disease

By  

Current Respiratory Medicine Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 226-232

Bentham Science Publishers

Access to resources Recommend Favorite

Difficulties in diagnosis of systemic sclerosis‐related interstitial lung disease

By  

Respirology Case Reports, Vol. 3, Iss. 3, 2015-09 ,pp. : 99-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Treatment of Multiple Sclerosis with Beta-Interferon

By  

Neuroepidemiology, Vol. 31, Iss. 3, 2008-08 ,pp. : 157-158

Karger

Access to resources Recommend Favorite

Interstitial Lung Disease in Systemic Sclerosis

By Ostojic Predrag   Cerinic Marco   Silver Richard   Highland Kristin   Damjanov Nemanja  

Lung, Vol. 185, Iss. 4, 2007-08 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 4, 2011-03 ,pp. : 231-232

Karger

Access to resources Recommend Favorite